08:23 AM EST, 11/12/2024 (MT Newswires) -- Mirum Pharmaceuticals ( MIRM ) reported a Q3 net loss Tuesday of $0.30 per share, narrowing from a loss of $0.57 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.46 per share.

Total revenue for the quarter ended Sept. 30 was $90.4 million, up from $47.7 million a year earlier.

Analysts surveyed by Capital IQ expected $82 million.

Mirum shares were up nearly 1% in recent premarket activity.